Clinical Trial Update: Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports on optimizing therapy for type 2 diabetes patients with kidney involvement using empagliflozin and finerenone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Jardiance (empagliflozin)
• Kerendia (finerenone)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Diabetes Mellitus Type 2 With Proteinuria, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED